Female Urology

Latest News

FDA grants priority review to expanded indication of flibanserin in HSDD
FDA grants priority review to expanded indication of flibanserin in HSDD

July 24th 2025

The expanded labeling would enable the use of flibanserin to treat hypoactive sexual desire disorder in postmenopausal women.

Experts urge FDA to remove black box warning on low-dose vaginal estrogen
Experts urge FDA to remove black box warning on low-dose vaginal estrogen

July 18th 2025

Urology in focus: Key moments from 2025
Urology in focus: Key moments from 2025

July 18th 2025

Phase 3 data of oral sulopenem for uUTIs published in NEJM Evidence
Phase 3 data of oral sulopenem for uUTIs published in NEJM Evidence

June 25th 2025

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

May 16th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.